Related Experiment Video
Updated: Jun 3, 2026
Immunohistochemical Staining of B7-H1 (PD-L1) on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
Functional significance of B7-H1 expressed by human uveal melanoma cells
Renbing Jia1, Zhijun Jiao, Xiaofang Xu
1Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, PR China.
Abstract:
B7-H1, a recently described B7 family member, has been reported to negatively regulate T-cell function in most cancer cells. In this study, we sought to investigate B7-H1 expression in four uveal melanoma (UM) cells (OCM1, SP6.5, OM431 and VUP) to determine the functional significance of B7-H1 expression in T-cell immune response. Using flow cytometry (FCM), we demonstrated that SP6.5 cells had high B7-H1 protein expression, while the other three UM cell lines had none. However, all four UM cell lines expressed B7-H1 mRNA, as confirmed by reverse transcription-polymerase chain reaction. In co-culture experiments using B7-H1-expressing UM cells with T-cells, FCM to determine CD69 expression in T-cells revealed that SP6.5 cell-related B7-H1 inhibited T-cell activation. This effect was eliminated by B7-H1-targeted RNA interference. An Annexin V/PI double staining assay further showed that B7-H1 expressed by SP6.5 cells did not increase the apoptosis of T-cells, though it was found in a variety of other solid tumors. In conclusion, all the UM cell lines constitutively expressed B7-H1 mRNA, while B7-H1 protein was expressed at different levels. UM-related B7-H1 expression negatively regulated T-cell immune response through the inhibition of T-cell activation, and not through the promotion of T-cell apoptosis. This provides new insight into anti-tumor immunity against B7-H1-expressing UM cells.
Insights
B7-H1 protein on uveal melanoma cells inhibits T-cell activation, not apoptosis. This immune regulation insight is crucial for understanding anti-tumor immunity in B7-H1 expressing cancers.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- B7-H1 (Programmed death-ligand 1) is a key immune checkpoint molecule.
- It negatively regulates T-cell responses in various cancers.
- Its role in uveal melanoma (UM) immunity requires further investigation.
Purpose of the Study:
- To investigate B7-H1 expression in UM cell lines.
- To determine the functional impact of B7-H1 on T-cell immune response in UM.
Main Methods:
- Flow cytometry (FCM) for protein expression analysis.
- Reverse transcription-polymerase chain reaction (RT-PCR) for mRNA detection.
- Co-culture experiments with UM cells and T-cells.
- CD69 expression analysis for T-cell activation.
- Annexin V/PI staining for apoptosis assessment.
- B7-H1 targeted RNA interference to assess functional impact.
Main Results:
- All four UM cell lines (OCM1, SP6.5, OM431, VUP) expressed B7-H1 mRNA.
- Only SP6.5 cells exhibited high B7-H1 protein expression.
- B7-H1 from SP6.5 cells significantly inhibited T-cell activation (CD69 expression).
- This inhibitory effect was reversed by B7-H1 RNA interference.
- B7-H1 expression did not induce T-cell apoptosis.
Conclusions:
- UM cell lines exhibit differential B7-H1 protein expression despite consistent mRNA levels.
- UM-derived B7-H1 negatively regulates T-cell immune response by inhibiting T-cell activation.
- The mechanism involves T-cell activation inhibition, not apoptosis induction.
- Findings offer insights into anti-tumor immunity against B7-H1-expressing UM.
